Cargando…

Experimental Models of Neuromyelitis Optica

For a long time, the most important inflammatory demyelinating diseases of the central nervous system (CNS), for example, multiple sclerosis (MS) and neuromyelitis optica (NMO), were extremely hard to differentiate, often with severe consequences for affected patients. This changed with the discover...

Descripción completa

Detalles Bibliográficos
Autores principales: Bradl, Monika, Lassmann, Hans
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065348/
https://www.ncbi.nlm.nih.gov/pubmed/24345221
http://dx.doi.org/10.1111/bpa.12098
_version_ 1782322067953156096
author Bradl, Monika
Lassmann, Hans
author_facet Bradl, Monika
Lassmann, Hans
author_sort Bradl, Monika
collection PubMed
description For a long time, the most important inflammatory demyelinating diseases of the central nervous system (CNS), for example, multiple sclerosis (MS) and neuromyelitis optica (NMO), were extremely hard to differentiate, often with severe consequences for affected patients. This changed with the discovery of NMO‐immunoglobulin G (IgG), a specific autoantibody which was detected in the vast majority of NMO patients, and with the demonstration that this autoantibody targets aquaporin 4 (AQP4), a water channel found on astrocytes in the CNS. These findings paved the way for the generation of experimental models of NMO. This chapter will discuss the contribution of experimental models to NMO research and what key questions remain to be addressed.
format Online
Article
Text
id pubmed-4065348
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-40653482014-06-24 Experimental Models of Neuromyelitis Optica Bradl, Monika Lassmann, Hans Brain Pathol Mini‐Symposium: Neuromyelitis Optica (NMO), Part 2 For a long time, the most important inflammatory demyelinating diseases of the central nervous system (CNS), for example, multiple sclerosis (MS) and neuromyelitis optica (NMO), were extremely hard to differentiate, often with severe consequences for affected patients. This changed with the discovery of NMO‐immunoglobulin G (IgG), a specific autoantibody which was detected in the vast majority of NMO patients, and with the demonstration that this autoantibody targets aquaporin 4 (AQP4), a water channel found on astrocytes in the CNS. These findings paved the way for the generation of experimental models of NMO. This chapter will discuss the contribution of experimental models to NMO research and what key questions remain to be addressed. John Wiley and Sons Inc. 2013-12-18 /pmc/articles/PMC4065348/ /pubmed/24345221 http://dx.doi.org/10.1111/bpa.12098 Text en © 2013 The Authors. Brain Pathology published by John Wiley & Sons Ltd on behalf of International Society of Neuropathology. https://creativecommons.org/licenses/by-nc-nd/3.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Mini‐Symposium: Neuromyelitis Optica (NMO), Part 2
Bradl, Monika
Lassmann, Hans
Experimental Models of Neuromyelitis Optica
title Experimental Models of Neuromyelitis Optica
title_full Experimental Models of Neuromyelitis Optica
title_fullStr Experimental Models of Neuromyelitis Optica
title_full_unstemmed Experimental Models of Neuromyelitis Optica
title_short Experimental Models of Neuromyelitis Optica
title_sort experimental models of neuromyelitis optica
topic Mini‐Symposium: Neuromyelitis Optica (NMO), Part 2
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4065348/
https://www.ncbi.nlm.nih.gov/pubmed/24345221
http://dx.doi.org/10.1111/bpa.12098
work_keys_str_mv AT bradlmonika experimentalmodelsofneuromyelitisoptica
AT lassmannhans experimentalmodelsofneuromyelitisoptica